Skip to main content
OpenTrials
Completed

NCT Number: NCT01619267

Role of New Diagnostic Tool in Device (ICD / PM) Associated Infections

Infections related to implantable pacemakers or cardioverters defibrillators are sometimes difficult to be diagnosed. Diificulties in the diagnosis include a low sensitivity of standard markers of inflammation such as C-reactive protein or white blood cell count and the diagnosis is mainly based on the clinical presentation. The observational DIRT-study evaluates if new biomarkers may be more suitable to support a diagnosis of device associated infections than the currently available ones.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Biomarkers in Device Associated Infections

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Dubrava, Zagreb, Croatia

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • device associated infections

Exclusion criteria

  • malignancy
  • cytostatic or immunomodulating therapy

Treatment and study plan

Primary outcomes

  1. procalcitonine

    Time frame: no follow-up

    procalcitonine is determined at inclusion and correlated to infectíon status

Sponsors and collaborators

Lead sponsor

Deutsches Herzzentrum Muenchen

Other

Collaborators

  • University Hospital Dubrava

Registry information

Official study title

Device Associated Infections - Role of New Diagnostic Tools

Acronym: DIRT

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Jun 14, 2012
Registry last updated
Apr 10, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.